ABOUT US

Anavex utilizes precision genetic medicine to treat severe and devastating neurological disorders and is focusing on rare diseases with no available therapy (Rett syndrome) as well as neurodegenerative diseases that are on the rise due to aging populations (Parkinson's Disease and Alzheimer's Disease)

Anavex utilizes precision genetic medicine to treat severe and devastating neurological disorders and is focusing on rare diseases with no available therapy (Rett syndrome) as well as neurodegenerative diseases that are on the rise due to aging populations (Parkinson's Disease and Alzheimer's Disease)

OUR PIPELINE

*Orphan Drug Designation by FDA

*Orphan Drug Designation by FDA

ABOUT SIGMACEPTOR

“Pharmaceutical and biopharmaceutical discovery, research and development services, namely, the discovery, research and product development of pharmaceuticals and biologic agents for the prevention and treatment of human neurological and neurodegenerative disorders, pain and cancer”.